[1]Liu L, Zhu X D, Wang W Q, et al. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis[J]. Clin Cancer Res,2010,16(10):2740
[2]Chaffer C L, Weinberg R A. A perspective on cancer cell metastasis[J]. Science,2011,331(6024):1559
[3]Coghlin C, Murray G I. Current and emerging concepts in tumour metastasis[J]. J Pathol,2010,222(1):1
[4] Klein C A. Cancer: the metastasis cascade[J]. Science,2008,321(5897):1785
[5] Ledford H. Cancer theory faces doubts[J]. Nature,2011,472(7343):273
[6]Thiery J P, Acloque H, Huang R Y, et al. Epithelial-mesenchymal transitions in development and disease[J]. Cell,2009,139(7343):871
[7]Reiman J M, Knutson K L, Radisky D C.Immune promotion of epithelial mesenchymal transition and generation of breast cancer stem cells[J].Cancer Res,2010,70(8):3005
[8]Bannai S, Ishii T. Transport of cystine and cysteine and cell growth in cultured human diploid fibroblasts: effect of glutamate and homocysteate[J]. J Cell Physiol,1982,112(2):265
[9]Sato H, Shiiya A, Kimata M, et al. Redox imbalance in cystine/glutamate transporter-deficient mice[J]. J Biol Chem,2005,280(45):37423
[10]Huang Y, Dai Z, Barbacioru C, et al. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresis tance[J]. Cancer Res,2005,65(16):7446 [
[11]Calvert P, Yao K S, Hamilton T C, et al. Clinical studies of reversal of drug resistance based on glutathione[J]. Chem Biol Interact,1998,111(2):213
[12]Goto S, Yoshida K, Morikawa T, et al. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells[J]. Cancer Res,1995,55(19):4297 [13]Ruth S, Zvulun E. Regulation of autophagy by ROS:physiology and pathology[J].Cell,2011,36(1):30
[14]Chen R S, Song Y M, Zhou Z Y, et al. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/ b-catenin pathway[J]. Oncogene,2009,28(4): 599
[15]Christensen H N. Role of amino acid transport and countertransport in nutrition and metabolism[J]. Physiol Rev,1990,70(1): 43
[16]Chillaron J, Roca R, Valencia A, et al. Heteromeric amino acid transporters: biochemistry, genetics, and physiology[J]. Am J Physiol Renal Physiol,2001,281(6):995 [17]Reddy N M, Kleeberger S R, Bream J H, et al. Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling[J]. Oncogene,2008,27(44): 5821
[18]Seiler A, Schneider M, Förster H, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-and AIF-mediated cell death[J]. Cell Metab,2008,8(3): 237
[19]Guo W, Zhao Y, Zhang Z, et al. Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma[J]. Cancer Letters,2011,312(1): 55
[20]Lv Q, Wang W, Xue J, et al. DEDD Interacts with PI3KC3 to Activate Autophagy and Attenuate Epithelial–Mesenchymal Transition in Human Breast Cancer[J]. Cancer Res,2012,72(13): 3238